Anthonet Koen to Immunocompromised Host
This is a "connection" page, showing publications Anthonet Koen has written about Immunocompromised Host.
Connection Strength
0,233
-
Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children. Pediatrics. 2024 Oct 01; 154(4).
Score: 0,233
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.